TXMD - Therapeutics MD GAAP EPS of -$0.10 misses by $0.02 revenue of $18.67M misses by $10.72M
Therapeutics MD press release (NASDAQ:TXMD): Q4 GAAP EPS of -$0.10 misses by $0.02. Revenue of $18.67M (-17.4% Y/Y) misses by $10.72M. As of December 31, 2021, the Company’s cash on hand totaled $65.1 million, compared with $80.5 million as of December 31, 2020. Shares -2.88% PM.
For further details see:
Therapeutics MD GAAP EPS of -$0.10 misses by $0.02, revenue of $18.67M misses by $10.72M